GlaxoSmithKline Pharmaceuticals, a leading MNC in India, has achieved satisfactory performance during the year ended December 2010 and stepped up equity dividend to 400 per cent as against 300 per cent in the previous year. The company's consolidated net profit increased by 10.4 per cent to Rs.560.57 crore from Rs.507.86 crore. It provided Rs.17.69 crore for revised gratuity limits and actuarial charge on post-retirement benefits as exceptional item during 2010 which impacted its bottom line.
Its consolidated net sales increased by 12.8 per cent to Rs.2151 crore from Rs.1908 crore. The other operating income went up by 65.4 per cent to Rs.30.98 crore from Rs.18.73 crore and it earned interest income of Rs.99.63 crore as compared to Rs.84.68 crore in the previous year. Its EBDITA improved by 14 per cent to Rs.789.62 crore from Rs.692.85 crore.
The company's standalone net profit increased by 10 per cent to Rs.563.69 crore from Rs.512.29 crore. GSK's standalone net sales increased by 12.9 per cent to Rs.2112 crore from Rs.1871 crore in the previous year. The pharmaceutical business grew by 14.3 per cent.
GlaxoSmithKline Pharma net moves up by 10% in 2010, dividend at 400%
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment